Thursday, August 11, 2011


Effect of Perioperative AntiHER-2 therapy on Early Breast Cancer Study - Biological phase (EPHOS-B)

EPHOS-B is a Phase III, multicentre, three arm, randomised controlled trial in women with HER2+ early breast cancer. The primary objective of the trial is to determine whether pre-operative treatment of HER-2 positive breast cancer patients with anti HER-2 therapy inhibits proliferation or increases apoptosis.The Breast Cancer Clinical Trials Team at St. Margaret's Hospital, Epping and PAH, Harlow are recruiting patients into this trial Details about this trial are at CancerHelp UK or by telephone 01279 827396.